Treg therapy in transplantation: a general overview

Area of Science:

• Immunology
• Transplantation Medicine
• Cellular Therapy

Background:

• Solid organ and hematopoietic stem cell transplantation are vital for end-stage organ failure and hematological disorders.
• Graft rejection and graft-versus-host disease (GvHD) remain significant challenges, leading to tissue damage and mortality.
• Regulatory T cells (Tregs) are crucial for immune tolerance and preventing autoimmune responses.

Purpose of the Study:

• To review the biology of Tregs and their therapeutic potential in transplantation.
• To summarize methods for isolating and expanding Tregs for clinical use.
• To present findings from early clinical trials investigating Treg-based therapies.

Main Methods:

• Review of current literature on Treg biology and function.
• Analysis of Treg isolation and expansion techniques.
• Summary of data from ongoing and completed clinical trials involving Tregs.

Main Results:

• Tregs possess potent immunosuppressive properties beneficial for transplantation.
• Established protocols exist for Treg isolation and expansion.
• Initial clinical trials indicate the feasibility and potential safety of Treg therapy, though further investigation is needed.

Conclusions:

• Treg-based cellular therapy holds significant promise for mitigating GvHD and graft rejection.
• Optimization of Treg expansion and clinical application strategies are essential for future success.
• Continued research and clinical trials are necessary to fully realize the therapeutic potential of Tregs in transplantation.